drugset
drugset / Trial / NCT01903486

Assessing the Efficacy of Steroid Treatment of Achalasia

NCT01903486 ↗

Phase 4 Withdrawn Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

Would systemic steroids be an effective treatment in early variants of achalasia?

Timeline

Start
2013-03
Primary completion
2020-12-28
Completion
2020-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 40 mg Oral

Indications

achalasia